Pure and Mixed Desmoplastic Melanomas: A Retrospective Clinicopathologic Comparison of 33 Cases
- PMID: 33534213
- PMCID: PMC8310890
- DOI: 10.1097/DAD.0000000000001909
Pure and Mixed Desmoplastic Melanomas: A Retrospective Clinicopathologic Comparison of 33 Cases
Abstract
Background: Pure and mixed desmoplastic melanomas (DMs) may have different natural histories and behaviors.
Methods: We conducted a retrospective review of patients diagnosed with DM at our institution between January 1997 and April 2019. A total of 33 unique DMs were identified and subsequently analyzed based on the histologic type (pure vs. mixed).
Results: The majority (57.6%) of our cases were classified as pure histology. Patients with pure DMs were more likely to be men (P = 0.035) and be older than 65 years (P = 0.019) compared with patients with mixed DMs. Patients with mixed DM were more likely to have mitoses present (P = 0.001) compared with patients with pure DM. There were no differences in ulceration, perineural invasion, vascular invasion, or survival between patients with pure and mixed histologic subtypes. In addition, no differences in sentinel lymph node biopsy, radiation, or chemotherapy were noted between the 2 histologic subtypes. Immunohistochemistry showed that 27.3% of the pure DMs stained with Melan-A and HMB45 were positive for these immunomarkers.
Conclusions: Pure and mixed variants of DM were found to have similar clinicopathologic characteristics. Patients with the mixed histologic subtype were more likely to have mitoses, but no difference in the therapeutic management or patient survival was seen between the 2 subtypes.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Comment in
-
Pure and Mixed Desmoplastic Melanoma Subtypes Exhibit Distinct Genetic Drivers.Am J Dermatopathol. 2022 Jun 1;44(6):466-467. doi: 10.1097/DAD.0000000000002141. Epub 2022 Jan 7. Am J Dermatopathol. 2022. PMID: 34999597 No abstract available.
Similar articles
-
Mixed Versus Pure Variants of Desmoplastic Melanoma: The Cleveland Clinic Experience.Ann Plast Surg. 2018 Mar;80(3):277-281. doi: 10.1097/SAP.0000000000001225. Ann Plast Surg. 2018. PMID: 28984655 Free PMC article.
-
Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma.Cancer. 2006 Feb 15;106(4):900-6. doi: 10.1002/cncr.21635. Cancer. 2006. PMID: 16411225
-
Desmoplastic melanoma: is there a role for sentinel lymph node biopsy?Ann Surg Oncol. 2013 Jul;20(7):2345-51. doi: 10.1245/s10434-013-2883-z. Epub 2013 Feb 7. Ann Surg Oncol. 2013. PMID: 23389470 Free PMC article.
-
Desmoplastic melanoma: a review.J Am Acad Dermatol. 2013 May;68(5):825-33. doi: 10.1016/j.jaad.2012.10.041. Epub 2012 Dec 23. J Am Acad Dermatol. 2013. PMID: 23267722 Free PMC article. Review.
-
Sentinel lymph node biopsy in desmoplastic melanoma - the percent desmoplastic component matters: A systematic review.J Plast Reconstr Aesthet Surg. 2022 Dec;75(12):4441-4449. doi: 10.1016/j.bjps.2022.08.044. Epub 2022 Aug 28. J Plast Reconstr Aesthet Surg. 2022. PMID: 36283925
Cited by
-
A Physician's Guide to the Use of Gene Expression Profile Ancillary Diagnostic Testing for Cutaneous Melanocytic Neoplasms.J Clin Aesthet Dermatol. 2023 Apr;16(4):12-20. J Clin Aesthet Dermatol. 2023. PMID: 37077930 Free PMC article. Review.
-
Immunohistochemistry for Skin Cancers: New Insights into Diagnosis and Treatment of Melanoma.Cancers (Basel). 2025 May 25;17(11):1769. doi: 10.3390/cancers17111769. Cancers (Basel). 2025. PMID: 40507250 Free PMC article. Review.
-
Adjuvant Radiation Therapy in Desmoplastic Melanoma: A Scoping Review.Cancers (Basel). 2024 Nov 19;16(22):3874. doi: 10.3390/cancers16223874. Cancers (Basel). 2024. PMID: 39594829 Free PMC article.
References
-
- Pavri SN, Clune J, Ariyan S, Narayan D. Malignant Melanoma: Beyond the Basics. Plast Reconstr Surg. 2016;138(2):330e–340e. - PubMed
-
- Frydenlund N, Mahalingam M. Desmoplastic melanoma, neurotropism, and neurotrophin receptors--what we know and what we do not. Adv Anat Pathol. 2015;22(4):227–241. - PubMed
-
- Hadfield MJ, Helsing R, Grant-Kels JM. Desmoplastic melanoma: an updated clinical review and the emerging role of genetic markers and immunotherapies. Melanoma Res. 2020;30(5):429–432. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous